Single article

DOI: 10.47026/2413-4864-2023-1-53-62

Ivanova A.L., Karzakova L.M., Odintsova A.V., Kudryashov S.I., Bagildinskaya M.V., Zhuravleva N.V.

Characteristics of the Immune Status in Patients with Decompensation of Liver Cirrhosis

Keywords: liver cirrhosis, immune status, immunoglobulins, T-lymphocytes

Liver cirrhosis continues to be an acute problem of modern medicine due to the high rates of its prevalence and mortality. The high mortality rate is caused by the development of the number of life–threatening complications in decompensated forms of liver cirrhosis – hepatorenal syndrome, infections and varicose bleeding. Hepatorenal syndrome and infections are the result of immunological shifts occurring during decompensation of liver cirrhosis. Currently available literature data do not allow us to create a complete picture of the functional state of various links of adaptive immunity with decompensated liver cirrhosis. The aim of the research was to study the characteristic features of adaptive immunity in patients with decompensated liver cirrhosis. Material and methods. The prospective cohort study included 136 patients with decompensated liver cirrhosis, who received inpatient treatment in the hepatological department of the multidisciplinary hospital. The cohort of examined patients was divided into two groups, one of which included patients with liver cirrhosis of viral origin (n = 78), the other – patients with alcoholic liver cirrhosis (n = 58). In addition to the generally accepted standard methods, the patient examination program included immunological tests: identification of T- and B-lymphocytes, immunoregulatory and activated subpopulations of T-lymphocytes by the method of immunophenotyping peripheral blood mononuclear cells using monoclonal antibodies. The serum levels of immunoglobulins IgM, IgG, IgA, circulating immune complexes were determined by immunoturbidimetric method. Results. The study of indicators of the humoral link of adaptive immunity revealed an increase in the number of B cells, an increase in IgM, IgG, IgA and circulating immune complexes in patients with decompensated liver cirrhosis. The cellular link of adaptive immunity was characterized by an increase in the relative content of T helper cells, activated T cells against the background of a decrease in the number of immature T cells and T regulatory cells. Conclusions. The distinctive features of adaptive immunity in patients with decompensated liver cirrhosis are simultaneous activation of both humoral and cellular components, which, apparently, supports the systemic inflammatory process and the associated progressive liver fibrosis.

References

  1. Lazebnik L.B., Golovanova E.V., Turkina S.V. et al. Nealkogol’naya zhirovaya bolezn’ pecheni u vzroslyh: klinika, diagnostika, lechenie. Rekomendacii dlya terapevtov, tret’ya versiya [Non-alcoholic fatty liver disease in adults: clinic, diagnosis, treatment. Recommendations for therapists, third version]. Experimental and clinical gastroenterology, 2021, vol. 185, pp. 4–52. DOI: 10.31146/1682-8658-ecg-185-1-4-52.
  2. Asrani S.K., Devarbhavi H., Eaton J. et al. Burden of liver diseases in the world. J Hepatol, 2019, vol. 70, no. 1, pp. 151–171. DOI: 10.1016/j.jhep.2018.09.014.
  3. Barrow F., Khan S., Fredrickson G. et al. Microbiota-driven activation of intrahepatic b cells aggravates NASH through innate and adaptive signaling. Hepatology, 2021, vol. 74, pp. 704–722. DOI: 10.1002/hep.31755.
  4. Basho K., Zoldan K., Schultheiss M. et al. IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis. J Hepatol, 2021, vol. 74, no. 3, pp. 649–660. DOI:10.1016/j.jhep.2020.10.012.
  5. Bruzzì S., Sutti S., Giudici G. et al. B2-lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD). Free Radic Biol Med, 2018, vol. 124, pp. 249–259. DOI: 10.1016/j.freeradbiomed.2018.06.015.
  6. Chapel H. Haeney M. Misbah S. et al. Essentials of clinical immunology. Wiley Blackwell, 2014, vol. 6, pp. 3–24.
  7. Doi H., Hayashi E., Arai J. et al. Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia. J Gastroenterol Hepatol, 2018, 10. DOI:10.1111/jgh.14123.
  8. Doi H., Iyer T.K., Carpenter E. et al. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population. Hepatology, 2012, vol. 55, pp. 709–719. DOI: 10.1002/hep.24689.
  9. Fillatreau S. B cells and their cytokine activities implications in human diseases. Clin Immunol, 2018, vol. 186, pp. 26–31. DOI: 10.1016/j.clim.2017.07.020.
  10. Gluud C., Tage-Jensen U., Rubinstein E., Henriksen J.H. Autoantibodies and immunoglobulins in patients with alcoholic cirrhosis. Relation to measurements of hepatic function and hemodynamics. Digestion, 1984, vol. 30, no. 1, pp. 1–6. DOI:10.1159/000199084.
  11. Godfrey D.I., Uldrich A.P., McCluskey J. et al. The burgeoning family of unconventional T cells. Nat Immunol, (2015, vol. 16, pp. 1114–1123. DOI: 10.1038/ni.3298.
  12. Her Z., Tan J.H.L., Lim Y.S. et al. CD4 + T cells mediate the development of liver fibrosis in high fat diet-induced NAFLD in humanized mice. Front Immunol, 2020, vol. 11, pp. 580968. DOI: 10.3389/fimmu.2020.580968.
  13. Joshi N., Ayesha Q., Habibullah C.M. Immunological studies in HBV-related chronic liver diseases. Indian J Pathol Microbiol, 1990, vol. 33, no. 4, pp. 351–354.
  14. Katz S.C., Ryan K., Ahmed N. et al. Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis. J Immunol, 2011, vol. 187, pp. 1150–1156. DOI: 4049/jimmunol.1004077.
  15. Kronsten V.T., Woodhouse C.A., Zamalloa A. et al. Exaggerated inflammatory response to bacterial products in decompensated cirrhotic patients is orchestrated by interferons IL-6 and IL-8. Am J Physiol Gastrointest Liver Physiol, 2022, vol. 322, no. 5, pp. G489-G499. DOI:10.1152/ajpgi.00012.2022.
  16. Lackner C., Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol, 2019, vol. 70, no. 2, pp. 294–304. DOI: 10.1016/j.jhep.2018.12.003.
  17. Luo X.Y., Takahara T., Kawai K. et al. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet. Am J Physiol Gastrointest Liver Physiol, 2013, vol. 305, pp. G891–899. DOI: 10.1152/ajpgi.00193.2013.
  18. McGovern B.H., Golan Y., Lopez M. et al. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients. Clinical Infectious Diseases, 2007, vol. 44, no. 3, pp. 431–437. DOI: 10.1086/509580.
  19. Parola M., Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019, vol. 65, pp. 37–55. DOI:10.1016/j.mam.2018.09.002.
  20. Pennington D.J., Vermijlen D., Wise E.L. et al. The integration of conventional and unconventional T cells that characterizes cell-mediated responses. Adv Immunol, 2005, vol. 87, pp. 27–59. DOI: 10.1016/S0065-2776(05)87002-6.
  21. Pone E.J., Zan H., Zhang J. et al. Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.  Rev. Immunol, 2010, vol. 30, pp. 1–29. DOI: 10.1615/critrevimmunol.v30.i1.10.
  22. Reinert D.F., Allen J.P. The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res, 2002, vol. 26, no. 2, pp. 272–279.
  23. Rolla S., Alchera E., Imarisio C. et al. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. Clin Sci (Lond), 2016, vol. 130, pp. 193–203. DOI: 10.1042/CS20150405.
  24. Strnad P., Tacke F., Koch A., Trautwein C. Liver – guardian, modifier and target of sepsis. Nature Reviews. Gastroenterology & Hepatology, 2017, vol. 14, no. 1, pp. 55–66. DOI: 10.1038/nrgastro.2016.168.
  25. Sutti S., Albano E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol, 2020, vol. 17, pp. 81–92. DOI: 10.1038/s41575-019-0210-2.
  26. Zhang C., Li L., Feng K. et al. ‘Repair’ treg cells in tissue injury. Cell Physiol Biochem, 2017, vol. 43, pp. 2155–2169. DOI: 10.1159/000484295.

About authors

Ivanova Antonina L.
Post-Graduate Student of Internal Diseases Department, Chuvash State University, Russia, Cheboksary (ial.antonina@yandex.ru; ORCID: https://orcid.org/0000-0003-2054-7591)
Karzakova Luiza M.
Doctor of Medical Sciences, Professor, Head of Internal Diseases Department, Chuvash State University, Russia, Cheboksary (luizak58@mail.ru; ORCID: https://orcid.org/0000-0002-5899-6352)
Odintsova Anastasia V.
6th year Student, Medicine Faculty, Chuvash State University, Russia, Cheboksary (anastasia.od.99@mail.ru; ORCID: https://orcid.org/0000-0001-7069-5029)
Kudryashov Sergei I.
Candidate of Medical Sciences, Associate Professor, Department of Internal Diseases, Chuvash State University, Russia, Cheboksary (medicpro21@mail.ru; ORCID: https://orcid.org/0000-0003-2277-9425)
Bagildinskaya Marina V.
Head of the Centralized Clinical Diagnostic Laboratory, City Clinical Hospital № 1, Russia, Cheboksary (gkb1@med.cap.ru; ORCID: https://orcid.org/0000-0003-1369-3902)
Zhuravleva Nadezhda V.
Candidate of Medical Sciences, Associate Professor, Department of Internal Medicine , Chuvash State University, Russia, Cheboksary (zhuravlevanv@mail.ru; ORCID: https://orcid.org/0000-0001-6470-7724)

Article link

Ivanova A.L., Karzakova L.M., Odintsova A.V., Kudryashov S.I., Bagildinskaya M.V., Zhuravleva N.V. Characteristics of the Immune Status in Patients with Decompensation of Liver Cirrhosis [Electronic resource] // Acta medica Eurasica. – 2023. – №1. P. 53-62. – URL: https://acta-medica-eurasica.ru/en/single/2023/1/7/. DOI: 10.47026/2413-4864-2023-1-53-62.